“…Monocyte depletion studies demonstrated that peripheral-derived monocytes contribute to the pathophysiology of several neurological disorders, including but not limited to Alzheimer’s disease (AD), intracerebral hemorrhage, traumatic brain injury, and multiple sclerosis [ 51 , 52 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 ]. Mice receiving intravenous injections of clodronate had reduced numbers of CCR2+Ly6c hi monocytes infiltrating the brain following injury, suggesting subset control modulates tissue damage [ 52 ]. Importantly, the use of CCR2-/- mice revealed that altering monocyte influx directly affects the production of type1 interferon genes in resident microglial subsets [ 47 ].…”